Introduction
============

Cervical cancer is the fourth most frequently detected cancer among females, with estimated data of 569,847 new cases and 311,365 deaths in 2018 worldwide \[[@b1-crt-2019-053]\]. It is well established that human papillomavirus (HPV) is one of the most common sexually transmitted pathogens in the genital system, and persistent infection with high-risk HPV genotypes is the major cause of cervical cancer \[[@b2-crt-2019-053]\]. When calculated by site, cervix accounts for 83% of HPV-attributable cancer all over the world, two-thirds of which occur in less developed countries \[[@b3-crt-2019-053]\]. According to a guide for cervical control by the World Health Organization (WHO), the success of control and prevention for cervical cancer largely depend on HPV vaccination and cervical cancer screening to a great extent \[[@b4-crt-2019-053]\]. Moreover, females' awareness and attitude towards the etiology of cervical cancer, HPV and its vaccine greatly influence the uptake of vaccination and participation in screening \[[@b5-crt-2019-053],[@b6-crt-2019-053]\].

China is one of the largest developing country, which has been estimated with 98,900 new cases and 30,500 deaths annually according to nationwide cancer statistics by the National Cancer Center in 2015 \[[@b7-crt-2019-053]\]. However, these data likely underestimate the true disease burden of cervical cancer, since imparity exists in the opportunity of cervical cancer screening for women with various demographic and geographic factors throughout the country \[[@b8-crt-2019-053]\]. Furthermore, many rural women may fail to get HPV vaccination and cervical screening tests due to poverty, inadequate health service resources, and lack of knowledge \[[@b9-crt-2019-053]\]. It is widely accepted that health disparities are greatly affected by sociodemographic factors, such as housing, living, and work environment, health and social care services, education and unemployment and welfare \[[@b10-crt-2019-053]\], which closely relate to household registration status in China \[[@b11-crt-2019-053]\].

*Hukou*, a household registration status of Chinese, divides people into two sub-groups, which are local residents and internal migrants. Internal migrants in China usually refer to those who do not change their official *hukou* registration to the new location which they move to (i.e., floating population or non-permanent residents) \[[@b12-crt-2019-053]\]. China has a large number of internal migrants (almost 244.5 million in 2017) according to the 2018 Report on China\'s Migrant Population Development (<http://www.nhfpc.gov.cn/zhuz/xwfb/201812/a32a43b225a740c4bff8f2168b0e9688.shtml>). Shenzhen, as one of the economically developed cities in China, has approximately 65% of the population were internal migrants, reaching nearly 8.2 million by the end of 2017 according to the Shenzhen Statistical Yearbook, 2018 (<http://tjj.sz.gov.cn/xxgk/zfxxgkml/tjsj/tjnj/201812/t20181229_14966437.htm>). Researchers in Shenzhen find that the quality of primary health care given to migrants is less satisfactory than that provided to local residents \[[@b13-crt-2019-053]\]. Possible explanations found by previous studies are internal migrants have poorer sociodemographic characteristics than their local counterparts, such as lack of health insurance, which result in poor quality of health care received and the following unsatisfactory health outcome \[[@b14-crt-2019-053]\].

The successful implementation and high uptake of the HPV vaccine depend on people's knowledge of HPV infection, and the awareness of the effect of HPV vaccination on cervical cancer prevention \[[@b15-crt-2019-053]\]. Previous surveys on the awareness of HPV and attitudes towards the HPV vaccine have been conducted for various populations in China \[[@b16-crt-2019-053]-[@b18-crt-2019-053]\]. However, little attention has been given to people with different *hukou* statuses. Whether female migrants have accordant awareness and attitude towards HPV and its vaccine with local residents still remains uncertain. As HPV vaccines (Cervarix, Gardasil, and Gardasil 9) have been introduced in China only for a short time period, studies on females' attitude toward HPV vaccination are also essential to measure the effect of previous health education and also help the decision-making process of HPV vaccine promotion. In this study, we conducted a cross-sectional survey, and attempted to evaluate the awareness of HPV and the HPV vaccine, as well as the willingness to HPV vaccination among females local and migrant residents who participated in cervical cancer screening in Shenzhen, China. We further explored the factors associated with the willingness of HPV vaccination, in order to provide clues for the application of HPV vaccination among females with different *hukou* statuses in China.

Materials and Methods
=====================

1. Study population
-------------------

This survey on the attitude towards HPV and the HPV vaccine was conducted between January and June 2015 in 20 street blocks from all administrative districts of Shenzhen city, with a multistage, stratified cluster sampling method to obtain the present sample. First, we selected two street blocks from each administrative district by simple randomization. Second, the list of all healthcare institutions which could provide cervical cancer screening services in the selected street block was collected through the Cervical Cancer Prevention Network of Shenzhen city for convenience by existed contacts. Third, we divided these healthcare institutions into two categories based on the workload of cervical cancer screening in 2014, including category A (screening less than 500 women) and B (screening more than 500 women). Subsequently one representative healthcare institution from each category was selected by simple randomization. Lastly, women aged from 21 to 60 years old, living in the selected regions, without a history of HPV vaccination, volunteered to join the study were recruited when they received cervical cancer screening service in the healthcare institutions. The overall response rate was 93.86%. According to the *hukou* status, women recruited in the survey were grouped into two categories: local residents (residents with a *hukou* of Shenzhen city) and internal migrants (women living in Shenzhen but without a *hukou* of Shenzhen city). Besides, internal migrants were further divided into two groups based on their staying time in Shenzhen: non-permanent residents (women had stayed in Shenzhen for equal and more than six months), and floating population (women had stayed in Shenzhen for less than six months), consistent with the definition in The Administrative Measures for Population Statistics and Monitor published by the Shenzhen City Government (<http://www.sz.gov.cn/zfgb/2006/gb517/200810/t20081019_94738.htm>).

2. Data collection
------------------

The questionnaire used in the survey was modified and adapted from those used in Chinese populations based on published papers and expert opinions \[[@b16-crt-2019-053],[@b17-crt-2019-053]\] and was written in Mandarin Chinese in simple and clear language. It consisted of questions about sociodemographic characteristics, knowledge of HPV and the HPV vaccine, the willingness to vaccinate themselves and their daughter(s) with the HPV vaccine, the reasons against willingness to be vaccinated, and the acceptance of self-paying for HPV vaccination. Awareness of HPV was assessed using the question "Before today, had you heard of HPV?" Women who answered "yes" to this question were considered to be aware of HPV. Awareness of HPV vaccine was assessed in the same way. These questions have been previously reported in other studies in China \[[@b17-crt-2019-053],[@b18-crt-2019-053]\]. Some specific questions were also used to estimate women's knowledge for HPV and its vaccine preliminarily, such as "Is HPV infection a sexually transmitted infection?," "Can persistent infection of high-risk HPV lead to cervical cancer?," "Can HPV vaccine prevent cervical cancer?", and "Should HPV vaccination be received before the first sexual intercourse?" As previous studies did \[[@b19-crt-2019-053]\], the acceptance of HPV vaccination was assessed by asking "Are you willing to receive HPV vaccination for yourself?" and "Are you willing to receive HPV vaccination for your daughter? (only for women with daughter)." Some questions had three possible options (Yes/No/Don't know), while the option "Don't know" was considered an incorrect answer. Females who signed the informed consent completed the questionnaire with the help of trained research investigators. Survey data were double entered in a database developed by using EpiData (EpiData Association, Odense, Denmark).

3. Statistical analysis
-----------------------

Data were analyzed using SPSS ver. 20.0 (IBM Corp., Armonk, NY). The demographic characteristics of participants, awareness of HPV and the HPV vaccine, and willingness to be vaccinated were presented by frequencies and percentages. The chi-square test was used to analyze the difference between local residents and internal migrants. Logistic regression model was used to analyze the association of potential associated variables with the willingness of HPV vaccination. Variables in the univariate analysis were entered into a multivariate logistic regression model, in which adjusted odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. Stratified analysis was applied to detect whether the associated factors with the willingness of HPV vaccination were modified by the *hukou* status. We tested for multiplicative interactions by including the product term in multivariate logistic regression models. Statistical significance was assessed by two-tailed tests with a level of 0.05.

4. Ethical statement
--------------------

The study was approved by the Ethical Review Committee of Affiliated Shenzhen Maternity and Child Healthcare Hospital (No. 2013-004), Southern Medical University. Study objectives and questionnaire matters were explained to parents before the survey. Informed consent was obtained from each participant prior to our survey.

Results
=======

1. Demographic characteristics of all participants
--------------------------------------------------

A total of 9,855 females were included in the final analysis. Demographic characteristics of the study subjects were presented in [Table 1](#t1-crt-2019-053){ref-type="table"}. The mean age of these women was 37.09 years old (standard deviation, 7.48). Among them, 92% women were ethnic Han Chinese. The proportions of local residents, non-permanent residents, and floating population were 28.4%, 58.1%, and 13.6%, respectively. Forty-seven point two percent of women had not been educated higher than the junior middle school. The majority of them were married (90.6%) and only having one sexual partner in the past six months (92.5%). Twenty-three point two percent of them did not have a medical insurance and 14.4% of them had a low monthly income (less than 2,000 RMB). The percentages of women with an older age at menarche (≥ 12 years old) and at the first sexual intercourse (≥ 18 years old) were 89.0% and 93.5%, respectively. More than half of the participants (58.8%) had one or more daughters. All above demographic characteristics differently distributed in three groups according to *hukou* and resident status (all p \< 0.05).

2. Awareness and attitude of HPV and the HPV vaccine among females with different residence statuses in Shenzhen
----------------------------------------------------------------------------------------------------------------

As shown in [Table 2](#t2-crt-2019-053){ref-type="table"}, of females who responded to concerning questions, 42.3% had heard of HPV, and only 21.0% had heard of the HPV vaccine. When stratified by *hukou* and resident status, local residents had a relatively higher awareness of HPV (62.0% vs. 35.6% vs. 29.9%, p \< 0.001) and the HPV vaccine (35.3% vs. 15.4% vs. 14.8%, p \< 0.001) than non-permanent residents and floating population.

Among who had heard of HPV, 71.0% of them knew that HPV infection is a sexually transmitted infection, and 55.1% of them knew that the persistent infection of high-risk HPV could lead to cervical cancer. Meanwhile, among who had heard of the HPV vaccine, 57.5% of them knew that the HPV vaccine can prevent cervical cancer, however, only 25.4% of them knew that HPV vaccination should be received before the first sexual intercourse. When compared to non-permanent residents and floating population, local residents had a higher awareness for all the questions referred to HPV and the HPV vaccine (p \< 0.001).

Totally 63.3% of the participants were willing to take the HPV vaccine. Similarly, local residents had a higher willingness than non-permanent residents and floating population (68.5% vs. 62.5% vs. 56.2%, p \< 0.001). Seventy-three point nine percent of whom had one or more daughters were willing to vaccinate their daughters; however, the willingness to vaccinate their daughter(s) were not varied among females by the *hukou* and resident status. Among those who were willing to take the HPV vaccine, the acceptance to pay for the HPV vaccination by themselves was also higher in local residents (41.5% vs. 24.6% vs. 26.1%, p \< 0.001). In addition, the main reasons for the unwillingness of HPV vaccination were worrying the safety of the vaccine (39.3%), HPV vaccination not being widely accepted (20.1%), worrying the price (10.0%) and the effectiveness of vaccine (8.3%), not considering themselves at risk of cervical cancer (6.3%), and thinking no effect of vaccination because they had sexual intercourse before (3.3%), with a proportion of 12.7% for other unknown reasons.

3. Factors associated with the willingness to receive HPV vaccination among females in Shenzhen
-----------------------------------------------------------------------------------------------

The factors associated with the willingness to receive HPV vaccination among females were presented in [Table 3](#t3-crt-2019-053){ref-type="table"}. A high willingness was associated with younger ages at 30-39 years old (OR, 1.248; 95% CI, 1.127 to 1.381), being local residents (OR, 1.216; 95% CI, 1.057 to 1.398), higher levels of education (OR, 1.204; 95% CI, 1.074 to 1.350 for high school; OR, 1.353; 95% CI, 1.168 to 1.566 for college graduate or above), being married (OR, 1.212; 95% CI, 1.021 to 1.438), high monthly income ≥ 10,000 RMB (OR, 1.261; 95% CI, 1.039 to 1.531), having daughter(s) (OR, 1.355; 95% CI, 1.236 to 1.487), heard of HPV (OR, 1.431; 95% CI, 1.292 to 1.584), and heard of HPV vaccine (OR, 1.470; 95% CI, 1.293 to 1.670). When stratified by the *hukou* and residence status, we did not find significant difference on the associated factors between local residents and internal migrants, all p for interactions were \> 0.05 ([Table 4](#t4-crt-2019-053){ref-type="table"}).

Discussion
==========

Migrants were recognized as a particularly vulnerable population for the reason that they did not have the same rights to benefit from social security and welfare as the local permanent residents \[[@b20-crt-2019-053]\]. To our knowledge, it is the first study to compare females' awareness and attitude towards HPV and its vaccine between local and migrant residents in China, which could provide novel clues to cervical cancer prevention among internal migrants. We found local residents had the best awareness of HPV and its vaccine, followed by non-permanent residents and floating population. Similar findings were observed for the willingness of HPV vaccination.

There were several large sample surveys on HPV awareness among females in China, which reported the proportions of women who had heard of HPV ranged from 15.0%-44.9% \[[@b16-crt-2019-053],[@b17-crt-2019-053],[@b19-crt-2019-053],[@b21-crt-2019-053]\]. We observed a higher proportion of 62.0% among local residents, followed by 35.6% among non-permanent residents and 29.9% among floating population. When compared with data from developed countries, only local residents in Shenzhen had consistent awareness of HPV, since the proportion of heard of HPV were 87.7%, 61.6%, and 71.8% in the United States, United Kingdom, and Australia, respectively \[[@b22-crt-2019-053]\], indicating that women in richer regions might know more about HPV. Additionally, the proportion of heard of HPV vaccine was previously reported about 17.4% (95% CI, 13.06% to 22.20%) in Chinese female population from a meta-analysis of 58 observational studies \[[@b23-crt-2019-053]\]. Here we similarly observed a higher proportion among local residents (35.3%) except for non-permanent residents (15.4%) and floating population (14.8%). However, females' awareness of HPV vaccine was still far away from those in economically developed countries \[[@b22-crt-2019-053]\], in which a government-mediated program for HPV vaccination was established as WHO recommended. The potential association between socioeconomic characteristics and awareness of HPV and its vaccine required further studies, since populations in published surveys demonstrated a range of cultural, ethnic, socioeconomic and other differences.

Women' willingness to vaccinate themselves differed by *hukou* and residence statues, while the proportions of willingness to vaccinate their daughter(s) among non-permanent residents and floating population were in accord with that among local residents. Data showed that the acceptability was nearly or over 80% among Chinese general female population from several large sample surveys \[[@b16-crt-2019-053],[@b17-crt-2019-053],[@b19-crt-2019-053]\], which reflected a lower acceptability for HPV vaccination in Shenzhen. The major concerns against HPV vaccination varied between local residents and internal migrants. Both worries about the safety of the vaccine and considering HPV vaccination not being widely accepted affected local residents more than internal migrants. However, internal migrants paid more attention to the price and the effectiveness of HPV vaccine, as well as their self-perception risk of cervical cancer. Furthermore, poorer economic status might play an essential role in women's acceptability for HPV vaccination, as the willingness to pay for vaccination was relatively lower in internal migrants in our survey, which might correlate with the fact that most of them had low-income level.

In our study, internal migrants showed a poor knowledge of HPV and its vaccine, and a lower acceptability to HPV vaccination than their local counterparts. Perhaps reasons for these inequalities were their disparity on sociodemographic characteristics. We found that internal migrants were more likely to be younger, non-Han minority, low-educated, low-income, single, lack of health insurance, and earlier to be engaged in sexual activity, which gave evidence of their vulnerable living situations as other reported articles suggested \[[@b24-crt-2019-053]-[@b26-crt-2019-053]\]. However, we did not observe that the associated factors of the willingness to receive HPV vaccination varied between local residents and internal migrants. Despite of *hukou* and resident status, having daughter(s) and heard of HPV and its vaccine did increase the acceptability to HPV vaccination both for local residents and internal migrants. It was conventionally thought that parental factors involved in HPV vaccine acceptability for the children \[[@b27-crt-2019-053]\]. Possible explanations might be that mothers would pay more attention to HPV vaccination if they had daughter(s), leading to a higher awareness of HPV and its vaccine, which did help to improve the intention to vaccinate both themselves and their daughter(s). Compliance with previous studies \[[@b28-crt-2019-053]-[@b30-crt-2019-053]\], we found that women who had heard of HPV and its vaccine were more likely to accept it, emphasizing that insufficient knowledge about the vaccine might become another important attitudinal barrier to the uptake of vaccine among females.

Some limitations should be addressed. First, representative healthcare institutions that provided cervical cancer screening services were selected as the survey sites, in which both local residents and internal migrants shared the same opportunity to receive screening services. Although our findings cannot be generalized to the entire female population in Shenzhen, the study subjects could be a representative sample of women who participated in cervical cancer screening. In consideration of relative better health belief among screening women, the awareness and attitude towards HPV and its vaccine among Shenzhen females may be overestimated, further large sample population-based surveys are in demand. Second, our study focused on acceptability rather than uptake of the HPV vaccine, in a sample where HPV awareness was relatively low; therefore, it is unclear whether women' intentions to be vaccinated would translate into behavior. Third, some of women may not have fully understood the questions due to different education levels, resulting in potential bias. Nevertheless, we provided assistance from trained research investigators if they required help. Fourth, we did not use a standard scale for Knowledge-Attitude/Belief-Practice (KAP model) to evaluate women's HPV related knowledge and perceptions of HPV vaccination, which might impact on the accuracy and completeness of information collection. Because of the limited explorations in developing HPV KAP scale, Chinese scholars usually adopted self-draft questionnaires based on expert opinions and previous reports \[[@b16-crt-2019-053]-[@b19-crt-2019-053]\]. The present questionnaire we used was modified from published articles. As the assessment for the awareness and attitude of HPV and its vaccine based on individual items was consistent with previous studies, the validity should be guaranteed to a certain extent. Moreover, although this survey was conducted in 2015, the time before the introduction of HPV vaccines into mainland China, and the results might not reflect the present perception of HPV/HPV vaccine among Chinese women. Nevertheless, our findings could indicate background levels of women's awareness and attitude towards HPV and its vaccine. Further perspective studies are demanded to address the improvement of HPV knowledge after vaccine permission in China.

In conclusion, our study detected inequalities in awareness and attitude towards HPV and its vaccine between local and migrant residents who participated in cervical cancer screening in Shenzhen, which provide novel insights to find out key obstacles for the potential uptake of HPV vaccination. Except for age, education level, marital status, monthly income, having daughter(s), and heard of HPV and its vaccine, the *hukou* and resident status did impact on the willingness to receive HPV vaccination. Therefore, it is critical to implement effective health education campaigns to raise awareness and knowledge of HPV and its vaccine among internal migrants.
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###### 

Demographic characteristics of all participants

  Variable                                              Total (n=9,855)   Local residents (n=2,796)   Non-permanent residents (n=5,721)   Floating population (n=1,338)   p-value
  ----------------------------------------------------- ----------------- --------------------------- ----------------------------------- ------------------------------- ----------
  **Age (yr)**                                                                                                                                                            
   \< 30                                                1,207 (12.2)      158 (5.7)                   793 (13.9)                          256 (19.1)                      \< 0.001
   30-39                                                5,234 (53.1)      1,504 (53.8)                3,110 (54.4)                        620 (46.3)                      
   ≥ 40                                                 3,414 (34.6)      1,134 (40.6)                1,818 (31.8)                        462 (34.5)                      
  **Race**                                                                                                                                                                
   Han                                                  9,319 (92.7)      2,727 (97.5)                5,376 (94.0)                        1,036 (77.4)                    \< 0.001
   Other                                                716 (7.3)         69 (2.5)                    345 (6.0)                           302 (22.6)                      
  **Education**                                                                                                                                                           
   Junior school or below                               4,648 (47.2)      496 (17.7)                  3,304 (57.8)                        848 (63.4)                      \< 0.001
   High school                                          2,544 (25.8)      728 (26.0)                  1,529 (26.7)                        287 (21.4)                      
   College graduate or above                            2,510 (25.5)      1,560 (55.8)                851 (14.9)                          99 (7.4)                        
   Unknown                                              153 (1.6)         12 (0.4)                    37 (0.6)                            104 (7.8)                       
  **Marital status**                                                                                                                                                      
   Married                                              8,933 (90.6)      2,544 (91.0)                5,272 (92.2)                        1,117 (83.5)                    \< 0.001
   Single/Divorced/Widowed                              922 (9.4)         252 (9.0)                   449 (7.8)                           221 (16.5)                      
  **Medical insurance**                                                                                                                                                   
   No insurance                                         2,288 (23.2)      303 (10.8)                  1,590 (27.8)                        395 (29.5)                      \< 0.001
   Urban medical insurance                              3,951 (40.1)      1,798 (64.3)                1,874 (32.8)                        279 (20.9)                      
   Rural medical insurance                              1,294 (13.1)      222 (7.9)                   833 (14.6)                          239 (17.9)                      
   Commercial insurance or others                       2,322 (23.6)      473 (16.9)                  1,424 (24.9)                        425 (31.8)                      
  **Monthly income (RMB)**                                                                                                                                                
   \< 2,000                                             1,415 (14.4)      283 (10.1)                  858 (15.0)                          274 (20.5)                      \< 0.001
   2,000-3,999                                          2,989 (30.3)      405 (14.5)                  2,079 (36.3)                        505 (37.7)                      
   4,000-5,999                                          2,232 (22.6)      577 (20.6)                  1,419 (24.8)                        236 (17.6)                      
   6,000-9,999                                          1,571 (15.9)      659 (23.6)                  809 (14.1)                          103 (7.7)                       
   ≥ 10,000                                             1,236 (12.5)      776 (27.8)                  399 (7.0)                           61 (4.6)                        
   Unknown                                              412 (4.2)         96 (3.4)                    157 (2.7)                           159 (11.9)                      
  **Age at menarche (yr)**                                                                                                                                                
   \< 12                                                980 (9.9)         369 (13.2)                  510 (8.9)                           101 (7.5)                       \< 0.001
   ≥ 12                                                 8,768 (89.0)      2,395 (85.7)                5,147 (90.0)                        1,226 (91.6)                    
   Unknown                                              107 (1.1)         32 (1.1)                    64 (1.1)                            11 (0.8)                        
  **Age at sex debut (yr)**                                                                                                                                               
   \< 18                                                223 (2.3)         33 (1.2)                    124 (2.2)                           66 (4.9)                        \< 0.001
   ≥ 18                                                 9,214 (93.5)      2,632 (94.1)                5,380 (94.0)                        1,202 (89.8)                    
   Unknown                                              418 (4.2)         131 (4.7)                   217 (3.8)                           70 (5.2)                        
  **No. of the sexual partners in the past 6 months**                                                                                                                     
   1                                                    9,115 (92.5)      2,599 (93.0)                5,331 (93.2)                        1,185 (88.6)                    0.008
   ≥ 2                                                  441 (4.5)         105 (3.8)                   259 (4.5)                           77 (5.8)                        
   Unknown                                              299 (3.0)         92 (3.3)                    131 (2.3)                           76 (5.7)                        
  **Having daughter(s)**                                                                                                                                                  
   No                                                   3,847 (39.0)      1,193 (42.7)                2,147 (37.5)                        507 (37.9)                      \< 0.001
   Yes                                                  5,799 (58.8)      1,560 (55.8)                3,454 (60.4)                        785 (58.7)                      
   Unknown                                              209 (2.1)         43 (1.5)                    120 (2.1)                           46 (3.4)                        

Values are presented as number (%). The chi-square test was used and p \< 0.05 was considered as statistically significant.

###### 

Awareness and attitude of HPV and the HPV vaccine among females with different *hukou* and residence statuses

  Items                                                                                                                                  Total (n=9,855)   Local residents (n=2,796)   Non-permanent residents (n=5,721)   Floating population (n=1,338)   p-value
  -------------------------------------------------------------------------------------------------------------------------------------- ----------------- --------------------------- ----------------------------------- ------------------------------- ----------
  **Heard of HPV**                                                                                                                                                                                                                                         
   Yes                                                                                                                                   4,169 (42.3)      1,733 (62.0)                2,036 (35.6)                        400 (29.9)                      \< 0.001
   No                                                                                                                                    5,686 (57.7)      1,063 (38.0)                3,685 (64.4)                        938 (70.1)                      
  **Know that HPV infection is a sexually transmitted infection^[a)](#tfn1-crt-2019-053){ref-type="table-fn"}^**                                                                                                                                           
   Yes                                                                                                                                   2,958 (71.0)      1,373 (79.2)                1,360 (66.8)                        225 (56.2)                      \< 0.001
   No                                                                                                                                    1,211 (29.0)      360 (20.8)                  676 (33.2)                          175 (43.8)                      
  **Know that the persistent infection of high-risk HPV could lead to cervical cancer^[a)](#tfn1-crt-2019-053){ref-type="table-fn"}^**                                                                                                                     
   Yes                                                                                                                                   2,296 (55.1)      1,135 (65.5)                996 (48.9)                          165 (41.2)                      \< 0.001
   No                                                                                                                                    1,873 (44.9)      598 (34.5)                  1,040 (51.1)                        235 (58.8)                      
  **Heard of the HPV vaccine**                                                                                                                                                                                                                             
   Yes                                                                                                                                   2,065 (21.0)      986 (35.3)                  881 (15.4)                          198 (14.8)                      \< 0.001
   No                                                                                                                                    7,790 (79.0)      1,810 (64.7)                4,840 (84.6)                        1,140 (85.2)                    
  **Know that the HPV vaccine can prevent cervical cancer^[b)](#tfn2-crt-2019-053){ref-type="table-fn"}^**                                                                                                                                                 
   Yes                                                                                                                                   1,188 (57.5)      648 (65.7)                  451 (51.2)                          89 (44.9)                       \< 0.001
   No                                                                                                                                    877 (42.5)        338 (34.3)                  430 (48.8)                          109 (55.1)                      
  **Know that HPV vaccination should be received before the first sexual intercourse^[b)](#tfn2-crt-2019-053){ref-type="table-fn"}^**                                                                                                                      
   Yes                                                                                                                                   524 (25.4)        293 (29.7)                  196 (22.2)                          35 (17.7)                       \< 0.001
   No                                                                                                                                    1,541 (74.6)      693 (70.3)                  685 (77.8)                          163 (82.3)                      
  **Willing to vaccinate themselves**                                                                                                                                                                                                                      
   Yes                                                                                                                                   6,241 (63.3)      1,916 (68.5)                3,573 (62.5)                        752 (56.2)                      \< 0.001
   No                                                                                                                                    3,614 (36.7)      880 (31.5)                  2,148 (37.5)                        586 (43.8)                      
  **Willing to vaccinate their daughter(s)^[c)](#tfn3-crt-2019-053){ref-type="table-fn"}^**                                                                                                                                                                
   Yes                                                                                                                                   4,284 (73.9)      1,170 (75.0)                2,551 (73.9)                        563 (71.7)                      0.233
   No                                                                                                                                    1,515 (26.1)      390 (25.0)                  903 (26.1)                          222 (28.3)                      
  **The reasons for unwilling to take the HPV vaccine^[d)](#tfn4-crt-2019-053){ref-type="table-fn"}^**                                                                                                                                                     
   Worry about the safety                                                                                                                1,419 (39.3)      384 (43.6)                  838 (39.0)                          197 (33.6)                      \< 0.001
   The HPV vaccine has not been widely accepted                                                                                          727 (20.1)        219 (24.9)                  409 (19.0)                          99 (16.9)                       
   Worry about the price                                                                                                                 361 (10.0)        40 (4.5)                    255 (11.9)                          66 (11.3)                       
   Worry about the effectiveness                                                                                                         301 (8.3)         55 (6.2)                    193 (9.0)                           53 (9.0)                        
   Not considering themselves at risk of cervical cancer                                                                                 229 (6.3)         31 (3.5)                    154 (7.2)                           44 (7.5)                        
   The vaccine isn\'t protective because they have sexual intercourse                                                                    118 (3.3)         23 (2.6)                    59 (2.7)                            36 (6.1)                        
   Other reasons                                                                                                                         459 (12.7)        128 (14.5)                  240 (11.2)                          91 (15.5)                       
  **Accept that they pay for the HPV vaccination by themselves^[e)](#tfn5-crt-2019-053){ref-type="table-fn"}^**                                                                                                                                            
   Yes                                                                                                                                   1,870 (30.0)      796 (41.5)                  878 (24.6)                          196 (26.1)                      \< 0.001
   No                                                                                                                                    4,371 (70.0)      1,120 (58.5)                2,695 (75.4)                        556 (73.9)                      

Values are presented as number (%). The chi-square test was used and p \< 0.05 was considered as statistically significant.

Only females who have heard of human papillomavirus (HPV) answered these questions,

Only females who have heard of the HPV vaccine answered these questions,

Only females who have daughter(s) answered the question,

Only females who are not willing to take the HPV vaccine answered the question,

Only females who are willing to take the HPV vaccine answered the question.

###### 

Factors associated with the willingness to receive HPV vaccination among females

  Variable                                          Willingness to receive HPV vaccination (n=9,855)   
  ------------------------------------------------- -------------------------------------------------- ---------------------
  **Age (yr)**                                                                                         
   ≥ 40                                             1.000 (reference)                                  1.000 (reference)
   30-39                                            1.342 (1.228-1.211)                                1.248 (1.127-1.381)
   \< 30                                            1.059 (0.926-1.211)                                1.109 (0.951-1.294)
  **Race**                                                                                             
   Other                                            1.000 (reference)                                  1.000 (reference)
   Han                                              1.183 (1.013-1.382)                                0.960 (0.796-1.159)
  ***Hukou* and resident status**                                                                      
   Floating population                              1.000 (reference)                                  1.000 (reference)
   Non-permanent residents                          1.296 (1.149-1.462)                                1.134 (0.954-1.349)
   Local residents                                  1.697 (1.483-1.941)                                1.216 (1.057-1.398)
  **Education**                                                                                        
   Junior school or below                           1.000 (reference)                                  1.000 (reference)
   High school                                      1.374 (1.243-1.519)                                1.204 (1.074-1.350)
   College graduate or above                        1.907 (1.717-2.118)                                1.353 (1.168-1.566)
  **Marital status**                                                                                   
   Single/Divorced/Widowed                          1.000 (reference)                                  1.000 (reference)
   Married                                          1.317 (1.148-1.512)                                1.212 (1.021-1.438)
  **Medical insurance**                                                                                
   No insurance                                     1.000 (reference)                                  1.000 (reference)
   Urban medical insurance                          1.263 (1.135-1.405)                                1.015 (0.898-1.148)
   Rural medical insurance                          0.931 (0.810-1.070)                                1.001 (0.862-1.164)
   Commercial insurance or others                   1.063 (0.943-1.197)                                1.014 (0.888-1.158)
  **Monthly income (RMB)**                                                                             
   \< 2,000                                         1.000 (reference)                                  1.000 (reference)
   2,000-3,999                                      1.033 (0.909-1.175)                                0.964 (0.838-1.109)
   4,000-5,999                                      1.264 (1.103-1.449)                                1.024 (0.881-1.191)
   6,000-9,999                                      1.437 (1.238-1.668)                                1.037 (0.875-1.229)
   ≥ 10,000                                         1.959 (1.662-2.310)                                1.261 (1.039-1.531)
  **Age at menarche (yr)**                                                                             
   \< 12                                            1.000 (reference)                                  1.000 (reference)
   ≥ 12                                             0.840 (0.730-0.966)                                0.921 (0.791-1.073)
  **Age at sex debut (yr)**                                                                            
   \< 18                                            1.000 (reference)                                  1.000 (reference)
   ≥ 18                                             1.509 (1.156-1.970)                                1.198 (0.888-1.617)
  **No. of the sexual partners in the past 6 mo**                                                      
   1                                                1.000 (reference)                                  1.000 (reference)
   ≥ 2                                              1.144 (0.935-1.401)                                1.192 (0.958-1.484)
  **Having daughter(s)**                                                                               
   No                                               1.000 (reference)                                  1.000 (reference)
   Yes                                              1.315 (1.208-1.431)                                1.355 (1.236-1.487)
  **Heard of HPV**                                                                                     
   No                                               1.000 (reference)                                  1.000 (reference)
   Yes                                              1.818 (1.670-1.980)                                1.431 (1.292-1.584)
  **Heard of the HPV vaccine**                                                                         
   No                                               1.000 (reference)                                  1.000 (reference)
   Yes                                              1.964 (1.760-2.190)                                1.470 (1.293-1.670)

Variables in univariate logistic regression models eventually entered the multivariable logistic regression model. HPV, human papillomavirus; OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval.

###### 

Factors associated with the willingness to receive HPV vaccination among females when stratified by *hukou* and residence status

  Variable                                          Willingness to receive HPV vaccination (n=9,855)                                                                             
  ------------------------------------------------- -------------------------------------------------- --------------------- ------- --------------------- --------------------- -------
  **Age (yr)**                                                                                                                                                                   
   ≥ 40                                             1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   30-39                                            1.645 (1.394-2.055)                                1.261 (1.133-1.403)           1.452 (1.195-1.765)   1.175 (1.042-1.325)   
   \< 30                                            1.432 (0.997-2.055)                                1.056 (0.910-1.226)   0.022   1.582 (1.037-2.415)   1.012 (0.856-1.197)   0.072
  **Race**                                                                                                                                                                       
   Other                                            1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   Han                                              0.886 (0.523-1.500)                                1.139 (0.967-1.343)   0.371   1.076 (0.606-1.912)   0.985 (0.809-1.200)   0.777
  **Education**                                                                                                                                                                  
   Junior school or below                           1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   High school                                      1.395 (1.102-1.765)                                1.357 (1.211-1.522)           1.152 (0.873-1.520)   1.236 (1.087-1.405)   
   College graduate or above                        1.950 (1.580-2.408)                                1.777 (1.525-2.070)   0.767   1.261 (0.943-1.687)   1.414 (1.180-1.696)   0.804
  **Marital status**                                                                                                                                                             
   Single/Divorced/Widowed                          1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   Married                                          1.356 (1.037-1.773)                                1.300 (1.107-1.526)   0.792   1.162 (0.839-1.619)   1.228 (1.003-1.502)   0.791
  **Medical insurance**                                                                                                                                                          
   No insurance                                     1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   Urban medical insurance                          1.379 (1.071-1.777)                                1.134 (1.000-1.287)           1.013 (0.753-1.361)   1.047 (0.913-1.202)   
   Rural medical insurance                          1.283 (0.890-1.849)                                0.872 (0.750-1.014)           1.526 (1.003-2.320)   0.928 (0.790-1.091)   
   Commercial insurance or others                   1.325 (0.978-1.793)                                1.002 (0.880-1.141)   0.221   1.045 (0.740-1.475)   1.007 (0.871-1.164)   0.072
  **Monthly income (RMB)**                                                                                                                                                       
   \< 2,000                                         1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   2,000-3,999                                      0.913 (0.667-1.248)                                1.070 (0.929-1.233)           0.753 (0.528-1.074)   1.025 (0.880-1.193)   
   4,000-5,999                                      1.120 (0.833-1.507)                                1.294 (1.109-1.511)           0.886 (0.631-1.245)   1.093 (0.923-1.294)   
   6,000-9,999                                      1.354 (1.010-1.814)                                1.382 (1.154-1.655)           0.995 (0.701-1.412)   1.078 (0.884-1.315)   
   ≥ 10,000                                         1.939 (1.447-2.599)                                1.583 (1.259-1.991)   0.217   1.306 (0.912-1.870)   1.152 (0.891-1.488)   0.163
  **Age at menarche (yr)**                                                                                                                                                       
   \< 12                                            1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   ≥ 12                                             0.985 (0.778-1.248)                                0.810 (0.680-0.964)   0.190   1.122 (0.865-1.455)   0.828 (0.685-1.001)   0.064
  **Age at sex debut (yr)**                                                                                                                                                      
   \< 18                                            1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   ≥ 18                                             2.666 (1.337-5.316)                                1.302 (0.974-1.740)   0.061   2.294 (0.958-5.498)   1.115 (0.810-1.534)   0.128
  **No. of the sexual partners in the past 6 mo**                                                                                                                                
   1                                                1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   ≥ 2                                              1.089 (0.710-1.669)                                1.184 (0.941-1.490)   0.734   1.178 (0.738-1.879)   1.204 (0.940-1.544)   0.934
  **Having daughter(s)**                                                                                                                                                         
   No                                               1.000 (reference.)                                 1.000 (reference)             1.000 (reference)     1.000 (reference)     
   Yes                                              1.218 (1.036-1.433)                                1.381 (1.250-1.525)   0.197   1.336 (1.116-1.598)   1.367 (1.227-1.523)   0.829
  **Heard of HPV**                                                                                                                                                               
   No                                               1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   Yes                                              1.858 (1.579-2.187)                                1.709 (1.540-1.896)   0.396   1.368 (1.126-1.661)   1.462 (1.297-1.649)   0.566
  **Heard of the HPV vaccine**                                                                                                                                                   
   No                                               1.000 (reference)                                  1.000 (reference)             1.000 (reference)     1.000 (reference)     
   Yes                                              2.118 (1.770-2.533)                                1.727 (1.498-1.990)   0.080   1.708 (1.392-2.097)   1.324 (1.125-1.560)   0.057

Variables in univariate logistic regression models eventually entered the multivariable logistic regression model. HPV, human papillomavirus; OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval.
